C38H45N5O5, triclinic, P1‾ (no. 2), a = 11.3541(16) Å, b = 12.1833(17) Å, c = 14.409(2) Å, α = 68.240(2)°, β = 76.613(3)°, γ = 88.873(3)°, V = 1796.0(4) Å3, Z = 2, Rgt(F) = 0.0620, wRref(F2) = 0.2023, T = 296 K
C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97....
C20H15N3O·H2O, triclinic, P1̅ (No. 2), a = 7.066(3) Å, b = 9.996(4) Å, c = 12.873(5) Å, α = 86.007(1...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
C32H31N5O2, triclinic, P1̄ (no. 2), a = 9.9226(4) Å, b = 11.1446(7) Å, c = 12.6719(6) Å, α = 90.693(...
C35H32N6O2, triclinic, P1‾$‾{1}$ (no. 2), a = 10.902(2) Å, b = 12.434(2) Å, c = 13.481(4) Å, ...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C26H18N2O8, triclinic, P1̅ (no. 2), a = 7.7679(19) Å, b = 11.000(3) Å, c = 13.370(3) Å, α = 75.682(5...
C24H17NO5, triclinic, P1̄ (no. 2), a = 8.5858(2) Å, b = 9.2397(4) Å, c = 13.7831(8) Å, α = 97.11(3)°...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
In the title compound, C35H27N3O3S, the spiro-linked five-membered rings both adopt twisted conforma...
In the title compound, C20H19NO5, the central six-membered ring has a slightly distorted half-chair ...
C21H34O3, orthorhombic, P212121 (no. 19), a = 7.5420(7) Å, b = 11.6929(11) Å, c = 22.657(2) Å, V = 1...
C20H21F2NO4, triclinic, P1‾$P‾{1}$ (no. 2), a = 8.6363(11) Å, b = 9.9144(11) Å, c = 11.8734(1...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
The title compound, C23H22N2O4S, crystallized with two independent molecules (A and B) in the asymme...
C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97....
C20H15N3O·H2O, triclinic, P1̅ (No. 2), a = 7.066(3) Å, b = 9.996(4) Å, c = 12.873(5) Å, α = 86.007(1...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
C32H31N5O2, triclinic, P1̄ (no. 2), a = 9.9226(4) Å, b = 11.1446(7) Å, c = 12.6719(6) Å, α = 90.693(...
C35H32N6O2, triclinic, P1‾$‾{1}$ (no. 2), a = 10.902(2) Å, b = 12.434(2) Å, c = 13.481(4) Å, ...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C26H18N2O8, triclinic, P1̅ (no. 2), a = 7.7679(19) Å, b = 11.000(3) Å, c = 13.370(3) Å, α = 75.682(5...
C24H17NO5, triclinic, P1̄ (no. 2), a = 8.5858(2) Å, b = 9.2397(4) Å, c = 13.7831(8) Å, α = 97.11(3)°...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
In the title compound, C35H27N3O3S, the spiro-linked five-membered rings both adopt twisted conforma...
In the title compound, C20H19NO5, the central six-membered ring has a slightly distorted half-chair ...
C21H34O3, orthorhombic, P212121 (no. 19), a = 7.5420(7) Å, b = 11.6929(11) Å, c = 22.657(2) Å, V = 1...
C20H21F2NO4, triclinic, P1‾$P‾{1}$ (no. 2), a = 8.6363(11) Å, b = 9.9144(11) Å, c = 11.8734(1...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
The title compound, C23H22N2O4S, crystallized with two independent molecules (A and B) in the asymme...
C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97....
C20H15N3O·H2O, triclinic, P1̅ (No. 2), a = 7.066(3) Å, b = 9.996(4) Å, c = 12.873(5) Å, α = 86.007(1...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...